title: Kinetics of antiviral activity by human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL) and rapid selection of CTL escape virus in vitro.
abstract: The antiviral activity of a CD8(+) cytotoxic T-lymphocyte (CTL) clone (TCC108) directed against a newly identified HLA-B14-restricted epitope, human immunodeficiency virus type 1 (HIV-1) Rev(67-75) SAEPVPLQL, was analyzed with respect to its kinetics of target cell lysis and inhibition of HIV-1 production. Addition of TCC108 cells or CD8(+) reverse transcriptase-specific CTLs to HLA-matched CD4(+) T cells at different times after infection with HIV-1 IIIB showed that infected cells became susceptible to CTL-mediated lysis before peak virus production but after the onset of progeny virus release. When either of these CTLs were added to part of the infected cells immediately after infection, p55 expression and virus production were significantly suppressed. These data support a model in which CTLs, apart from exerting cytolytic activity which may prevent continued virus release, can interfere with viral protein expression during the eclipse phase via noncytolytic mechanisms. TCC108-mediated inhibition of virus replication in peripheral blood mononuclear cells caused rapid selection of a virus with a mutation (69E-->K) in the Rev(67-75) CTL epitope which abolished recognition by TCC108 cells. Taken together, these data suggest that both cytolytic and noncytolytic antiviral mechanisms of CTLs can be specifically targeted to HIV-1-infected cells.
authors.affiliation: Institute of Virology, Erasmus University, Rotterdam, The Netherlands.
authors.forename: C A
authors.initials: CA
authors.lastname: Van Baalen
authors.forename: M
authors.initials: M
authors.lastname: Schutten
authors.forename: R C
authors.initials: RC
authors.lastname: Huisman
authors.forename: P H
authors.initials: PH
authors.lastname: Boers
authors.forename: R A
authors.initials: RA
authors.lastname: Gruters
authors.forename: A D
authors.initials: AD
authors.lastname: Osterhaus
mesh_terms: D000595:Amino Acid Sequence; D002460:Cell Line; D003601:Cytotoxicity Tests, Immunologic; D015694:Gene Products, rev / Q000276:immunology; D015658:HIV Infections / Q000097:blood / Q000276:immunology*; D054303:HIV Reverse Transcriptase / Q000276:immunology; D015497:HIV-1 / Q000254:growth & development / Q000276:immunology* / Q000502:physiology; D015234:HLA-A Antigens / Q000276:immunology; D015235:HLA-B Antigens / Q000276:immunology; D006801:Humans; D007700:Kinetics; D008969:Molecular Sequence Data; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D014779:Virus Replication; D054321:rev Gene Products, Human Immunodeficiency Virus
chemical_list: D015694:Gene Products, rev; D015234:HLA-A Antigens; D015235:HLA-B Antigens; D054321:rev Gene Products, Human Immunodeficiency Virus; D054303:HIV Reverse Transcriptase